Start Date
November 20, 2022
Primary Completion Date
October 24, 2024
Study Completion Date
October 24, 2024
Myfembree Oral Product
The study drug Myfembree will be taken orally with water, once daily, at approximately the same time, with or without food. Each tablet of Myfembree contains Relugolix 40mg, estradiol 1mg, and norethindrone acetate 0.5 mg.
University of Chicago Schererville, Schererville
University of Chicago Flossmoor, Flossmoor
University of Chicago Orland Park, Orland Park
University of Chicago South Loop, Chicago
University of Chicago River East, Chicago
University of Chicago DCAM, Chicago
Collaborators (1)
Myovant Sciences GmbH
INDUSTRY
University of Chicago
OTHER